Prescription Drug Supply Chain Pricing Transparency Act

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

Introduced in Senate Jan 29, 2026 · 818 words Open full page ↗

119TH CONGRESS

2D SESSION

S. 3751

To require the Comptroller General of the United States to conduct a study

and submit a report on price-related compensation and payment struc-

tures in the prescription drug supply chain.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Introduced — base rate 2%, measured from US's completed sessions
Momentum -7 17/100 from the pace of recorded action
Time since last action -22 261 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.